Latest StemPoint Capital LP Stock Portfolio

StemPoint Capital LP Performance:

2025 Q4: 14.18%YTD: 28.89%2024: 1.93%

Performance for 2025 Q4 is 14.18%, and YTD is 28.89%, and 2024 is 1.93%.

About StemPoint Capital LP and 13F Hedge Fund Stock Holdings

On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, STEMPOINT CAPITAL LP reported an equity portfolio of $583.2 Millions as of 31 Dec, 2025.

The top stock holdings of STEMPOINT CAPITAL LP are , SRRK, CNTA. The fund has invested 9.1% of it's portfolio in ABIVAX SA and 6.7% of portfolio in SCHOLAR ROCK HLDG CORP.

The fund managers got completely rid off WAVE LIFE SCIENCES LTD (WVE), BIOHAVEN LTD and CIDARA THERAPEUTICS INC (CDTX) stocks. They significantly reduced their stock positions in UNIQURE NV (QURE), TAYSHA GENE THERAPIES INC (TSHA) and ROIVANT SCIENCES LTD (ROIV). STEMPOINT CAPITAL LP opened new stock positions in TWIST BIOSCIENCE CORP (TWST), ADAPTIVE BIOTECHNOLOGIES COR (ADPT) and PALISADE BIO INC (PALI). The fund showed a lot of confidence in some stocks as they added substantially to ARCELLX INC (ACLX), CLEARPOINT NEURO INC (CLPT) and INVENTIVA SA (IVA).

StemPoint Capital LP Annual Return Estimates Vs S&P 500

Our best estimate is that STEMPOINT CAPITAL LP made a return of 14.18% in the last quarter. In trailing 12 months, it's portfolio return was 28.89%.

Performance
S&P 500

New Buys

Ticker	$ Bought
twist bioscience corp	16,442,200
adaptive biotechnologies cor	9,854,840
palisade bio inc	9,852,080
cytokinetics inc	9,338,980
edgewise therapeutics inc	8,955,140
bright minds biosciences inc	7,596,410
johnson & johnson	7,243,250
eyepoint inc	6,464,820

New stocks bought by StemPoint Capital LP

Additions

Ticker	% Inc.
arcellx inc	2,825
clearpoint neuro inc	2,793
inventiva sa	1,415
arbutus biopharma corp	380
terns pharmaceuticals inc	378
invivyd inc	255
meiragtx hldgs plc	251
whitehawk therapeutics inc	243

Additions to existing portfolio by StemPoint Capital LP

Reductions

Ticker	% Reduced
uniqure nv	-91.67
taysha gene therapies inc	-78.31
roivant sciences ltd	-76.97
denali therapeutics inc	-75.84
vistagen therapeutics inc	-75.22
revolution medicines inc	-66.54
immunovant inc	-59.43
ideaya biosciences inc	-56.52

StemPoint Capital LP reduced stake in above stock

Sold off

Ticker	$ Sold
wave life sciences ltd	-15,446,300
equillium inc	-2,729,780
biohaven ltd	-15,269,800
rezolute inc	-8,625,720
pyxis oncology inc	-1,530,770
gh research plc	-7,797,430
pepgen inc	-1,798,050
protara therapeutics inc	-1,581,950

StemPoint Capital LP got rid off the above stocks

Sector Distribution

STEMPOINT CAPITAL LP has about 76% of it's holdings in Healthcare sector.

Sector	%
Healthcare	76
Others	23.6

Market Cap. Distribution

STEMPOINT CAPITAL LP has about 10.4% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
MID-CAP	44.1
UNALLOCATED	23.6
SMALL-CAP	16.3
LARGE-CAP	7.3
MICRO-CAP	5
MEGA-CAP	3.1

Stocks belong to which Index?

About 53.8% of the stocks held by STEMPOINT CAPITAL LP either belong to S&P 500 or RUSSELL 2000 index.

Index	%
RUSSELL 2000	50.3
Others	46.2
S&P 500	3.5

Top 5 Winners (%)		%
TERN	terns pharmaceuticals inc	96.9 %
CELC	celcuity inc	95.0 %
	mbx biosciences inc	77.0 %
	structure therapeutics inc	69.1 %
ADGI	invivyd inc	55.1 %

Top 5 Winners ($)		$
ROIV	roivant sciences ltd	17.0 M
	abivax sa	13.9 M
IMVT	immunovant inc	10.4 M
	structure therapeutics inc	10.0 M
TERN	terns pharmaceuticals inc	8.5 M

Top 5 Losers (%)		%
VSTA	vistagen therapeutics inc	-57.8 %
QURE	uniqure nv	-32.0 %
CLPT	clearpoint neuro inc	-23.5 %
NKTR	nektar therapeutics	-18.3 %
ACLX	arcellx inc	-11.8 %

Top 5 Losers ($)		$
QURE	uniqure nv	-9.7 M
VSTA	vistagen therapeutics inc	-4.5 M
ACLX	arcellx inc	-2.9 M
CLPT	clearpoint neuro inc	-2.0 M
NKTR	nektar therapeutics	-1.7 M

StemPoint Capital LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of StemPoint Capital LP

STEMPOINT CAPITAL LP has 75 stocks in it's portfolio. About 45.6% of the portfolio is in top 10 stocks. QURE proved to be the most loss making stock for the portfolio. ROIV was the most profitable stock for STEMPOINT CAPITAL LP last quarter.

Last Reported on: 17 Feb, 2026

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
AADI	whitehawk therapeutics inc	0.60	1,458,810	3,530,310	added	243

ABBV	abbvie inc	0.36	9,325	2,130,670	new

ABUS	arbutus biopharma corp	0.81	986,751	4,746,270	added	380

ACLX	arcellx inc	3.72	332,860	21,702,500	added	2,825

ADCT	adc therapeutics sa	0.30	502,570	1,774,070	added	77.41

ADGI	invivyd inc	0.42	989,822	2,444,860	added	255

ADPT	adaptive biotechnologies cor	1.69	606,825	9,854,840	new

AGLE	spyre therapeutics inc	0.18	32,377	1,060,670	new

ALKS	alkermes plc	0.00	0.00	0.00	sold off	-100

AMLX	amylyx pharmaceuticals inc	1.17	565,140	6,826,890	added	104

ARCT	arcturus therapeutics hldgs	0.00	0.00	0.00	sold off	-100

ARGX	argenx se	0.00	0.00	0.00	sold off	-100

ARQT	arcutis biotherapeutics inc	1.12	224,740	6,526,450	reduced	-45.44

ASMB	assembly biosciences inc	0.91	156,728	5,330,320	added	137

ASND	ascendis pharma a/s	0.54	14,842	3,164,910	reduced	-2.03

ATAI	atai life sciences nv	0.00	0.00	0.00	sold off	-100

AVTX	avalo therapeutics inc	0.42	135,552	2,461,620	new

BBIO	bridgebio pharma inc	0.00	0.00	0.00	sold off	-100

BLTE	belite bio inc	0.25	9,163	1,465,710	new

CAPR	capricor therapeutics inc	0.09	17,853	515,238	new